Alyeska Investment Group
MBII

Alyeska Investment Group’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Alyeska Investment Group’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-153,308
Closed -$169K – 475
2015
Q4 		$169K Sell
153,308
-44,573
-23% -$95.5K ﹤0.01% 364
2015
Q3 		$418K Buy
197,881
+13,844
+8% +$27K ﹤0.01% 430
2015
Q2 		$364K Buy
184,037
+53,506
+41% +$152K ﹤0.01% 466
2015
Q1 		$505K Buy
130,531
+9,598
+8% +$35.5K 0.01% 467
2014
Q4 		$437K Sell
120,933
-4,479
-4% -$11.9K 0.01% 449
2014
Q3 		$334K Sell
125,412
-253,059
-67% -$1.69M 0.01% 364
2014
Q2 		$4.4M Buy
378,471
+111,480
+42% +$1.26M 0.1% 244
2014
Q1 		$3.73M Buy
266,991
+60,273
+29% +$947K 0.1% 224
2013
Q4 		$3.67M Buy
206,718
+7,918
+4% +$129K 0.15% 186
2013
Q3 		$3.35M Buy
+198,800
New +$2.79M 0.14% 184

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EAM
Evanson Asset Management Carmel, California $1.86B AUM 25.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alyeska Investment Group's MBII Position: Q1 2016 in Review

Alyeska Investment Group sold out of Marrone Bio Innovations, Inc. (MBII) in Q1 2016, closing a stake of 153,308 shares — an estimated $169K sold.

Alyeska Investment Group first reported a position in MBII in Q3 2013 and held it in 10 quarters. The position peaked at $4.4M in Q2 2014. 23 funds tracked by Wall St. Rank hold MBII as of Q1 2016.

  • Alyeska Investment Group reported no remaining Marrone Bio Innovations, Inc. position as of Q1 2016 after selling out during the quarter.
  • Alyeska Investment Group sold 153,308 Marrone Bio Innovations, Inc. shares in Q1 2016, an estimated $169K.
  • Alyeska Investment Group first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 10 quarters.
  • Alyeska Investment Group's Marrone Bio Innovations, Inc. position peaked at $4.4M in Q2 2014.
  • 23 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2016.

Based on Alyeska Investment Group's 13F filing for Q1 2016, filed 16 May 2016.